These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7398682)

  • 1. Binding of tienilic acid (Diflurex) to human serum albumin and to plasma of normal subjects and uraemic patients.
    Prandota J; Tillement JP; d'Athis P; Drüeke T; Digiulio S
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):99-106. PubMed ID: 7398682
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of Tienilic acid (Diflurex) to human plasma proteins and erythrocytes.
    Plessas C; Benakis A
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):107-12. PubMed ID: 7398676
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tienilic acid (Diflurex) on the binding of warfarin 14C to human plasma proteins.
    Prandota J; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):158-62. PubMed ID: 7380589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of ethacrynic and tienilic acid in plasma by gas--liquid chromatography--mass spectrometry.
    Stüber W; Mutschler E; Steinbach D
    J Chromatogr; 1982 Jan; 227(1):193-8. PubMed ID: 7056811
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic studies of tienilic acid in healthy volunteers.
    Kerremans AL; Gribnau FW; Tan Y; van Ginneken CA
    Eur J Clin Pharmacol; 1982; 22(6):515-21. PubMed ID: 7128663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 7. Extraction of uraemic toxins with activated carbon restores the functional properties of albumin.
    Sarnatskaya VV; Lindup WE; Ivanov AI; Yushko LA; Tjia J; Maslenny VN; Gurina NM; Nikolaev VG
    Nephron Physiol; 2003; 95(1):p10-8. PubMed ID: 14520007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative thin-layer chromatographic determination of ticrynafen in plasma of the dog.
    Vukusić I; Vovopivec P
    J Chromatogr; 1981 Feb; 222(2):324-8. PubMed ID: 7251750
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diflurex (tienilic acid) in the treatment of gout].
    Bosmanský K; Trnavský K; Pullmann R
    Fysiatr Revmatol Vestn; 1983 Oct; 61(5):264-9. PubMed ID: 6685680
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Clegg LS; Lindup WE
    Biochem Pharmacol; 1982 Sep; 31(17):2791-4. PubMed ID: 7138574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein binding of piretanide in normal and uraemic serum.
    Elliott HL; Ansari AF; Campbell BC; Lawrence JR
    Eur J Clin Pharmacol; 1982; 21(4):311-3. PubMed ID: 7056276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tienilic acid, hyperuricemia and kidney function].
    de Torrenté A
    Schweiz Med Wochenschr; 1981 Mar; 111(11):381-5. PubMed ID: 7221513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein binding and interaction studies with piroxicam.
    Trnavská Z; Trnavský K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):81-5. PubMed ID: 6493354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticrynafen in anephric patients: effects on uric acid and pharmacokinetics.
    Murray TG; Brown S; Dubb JW; Hwang BY; Stote RM
    Clin Pharmacol Ther; 1980 May; 27(5):686-9. PubMed ID: 7371365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of tienilic acid (ticrynafen) in man. Pharmacokinetic and mass spectrometric studies.
    Vinay P; Paquin J; Lemieux G; Gougoux A; Bertrand M
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):113-25. PubMed ID: 7398677
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin.
    Henderson SJ; Lindup WE
    Biochem Pharmacol; 1990 Dec; 40(11):2543-8. PubMed ID: 2268372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid.
    Ivarsen R; Brodersen R
    Dev Pharmacol Ther; 1989; 12(1):19-29. PubMed ID: 2566458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum albumin binding capacity for bromsulfophthalein in patients with uremia during hemodialysis].
    Erich C; Eggstein M
    Klin Wochenschr; 1972 Jul; 50(13):658-60. PubMed ID: 5047904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.